Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing nanobiotechnology for cerebral ischemic stroke management
Lu Tang, Cong Fu, Aining Zhang, et al.
Biomaterials Science (2022) Vol. 11, Iss. 3, pp. 791-812
Closed Access | Times Cited: 19

Showing 19 citing articles:

Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy
Lu Tang, Yue Yin, Hening Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 26
Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes
Virendra Kumar Yadav, Rachna Gupta, Abdullah Assiri, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 1, pp. 8-8
Open Access | Times Cited: 1
Nanosystems in Cardiovascular Medicine: Advancements, Applications, and Future Perspectives
Hossein Omidian, Niloofar Babanejad, Luigi X. Cubeddu
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1935-1935
Open Access | Times Cited: 20
Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system
Wei Liu, Lubin Liu, Hong Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system
Qian Luo, Jiaying Yang, Mei Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101457-101457
Open Access
Fluoxetine‐induced downregulation of circMap2k1 signaling cascade to improve neurological function after ischemic stroke
Linghui He, Hui Zhang, Jian Deng, et al.
Fundamental and Clinical Pharmacology (2025) Vol. 39, Iss. 1
Open Access
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 835-865
Open Access | Times Cited: 4
Deciphering the Mechanistic Impact of Acupuncture on the Neurovascular Unit in Acute Ischemic Stroke: Insights From Basic Research in a Narrative Review
Hailun Jiang, Chao Zhang, Mengxuan Lin, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102536-102536
Closed Access | Times Cited: 4
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access
Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke
Jiangjun Zhang, Zhong Chen, Qi Chen
Molecules (2024) Vol. 29, Iss. 8, pp. 1848-1848
Open Access | Times Cited: 3
Stroke Studies in Large Animals: Prospects of Mitochondrial Transplantation and Enhancing Efficiency using Hydrogels and Nanoparticle-assisted Delivery
Oner Ulger, Ismail Eş, Christopher M. Proctor, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102469-102469
Closed Access | Times Cited: 3
Advances in nanoparticle-based therapeutics for ischemic stroke: Enhancing drug delivery and efficacy
Peng Ji, Qingqing Xu, Jiahui Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117564-117564
Closed Access | Times Cited: 3
Il1r2 and Tnfrsf12a in transcranial magnetic stimulation effect of ischemic stroke via bioinformatics analysis
Man Zhao, A. Liu, Jiaojiao Wu, et al.
Medicine (2024) Vol. 103, Iss. 4, pp. e36109-e36109
Open Access | Times Cited: 2
Glycolytic reprogramming in microglia: A potential therapeutic target for ischemic stroke
Guangming Zhang, Anliu Zhao, Xiaolu Zhang, et al.
Cellular Signalling (2024), pp. 111466-111466
Closed Access | Times Cited: 2
Cell Membrane-Derived Nanovehicles for Targeted Therapy of Ischemic Stroke: From Construction to Application
Hao Cui, Sha Ma, Ye Yang, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 6-6
Open Access | Times Cited: 5
Current trends and future perspectives of stroke management through integrating health care team and nanodrug delivery strategy
Xuelu Han, Yingxin Qin, Chunli Mei, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 4
Nanomaterials for Stroke Diagnosis and Treatment
Yang Liu, Junying Li, Huaijuan Guo, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111112-111112
Closed Access | Times Cited: 1
ROS-responsive quercetin-based polydopamine nanoparticles for targeting ischemic stroke by attenuating oxidative stress and neuroinflammation
Chuyao Jian, Yigen Hong, Hongsheng Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125087-125087
Closed Access
Mechanism of fluoxetine downregulation of circMap2k1 to alleviate neurological function after ischemic stroke
Hui Zhang, Jian Deng, Yibo He, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top